Notch up another blockbuster drug for Eli Lilly and Co., thanks to the robust market for antidepressants. The Indianapolis drug maker said Wednesday that Cymbalta, which it launched just two years ago, rang up sales of $1.3 billion last year, nearly doubled from 2005.

[News Source]